LSTA Lisata Therapeutics - terminates merger agreement with kuva Labs on July 24, 2026 - SEC filing - Termination due to kuva Labs' failure
LSTA Lisata Therapeutics - terminates merger agreement with kuva Labs on July 24, 2026 - SEC filing - Termination due to kuva Labs' failure to obtain financing and accept tendered shares - SEC filing - Board to assess strategic options including reverse merger or asset sales - SEC filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.